1 UK Council for Science and Technology Two themes 1.The CST itself – who we are and how we operate 2.Our innovation agenda

2 Who we are Prime Minister’s top-level independent and impartial advisory body on strategic science and technology policy issues Focus on longer-term, cross-Government issues which are identified either by Government, or by the CST, or both Co-chaired by Sir David King – Government’s Chief Scientific Advisor, and me

3 Our Membership 17 independent members who are leaders drawn from academia and business Broad range of academic disciplines and business backgrounds

4 CST Members Sir David King Government Chief Scientific Advisor Sir Keith Peters President Academy of Medical Sciences Sir John Beringer Chair The John Innes Centre Professor Geoffrey Boulton Vice-Principal Edinburgh University Professor Janet Finch Vice-Chancellor Keele University Andrew Gould CEO Schlumberger Ltd Professor Wendy Hall Southampton University Dr Hermann Hauser Amadeus Capital Partners Dr Dieter Helm Oxford University Professor Alan Hughes Cambridge University Dr Sue Ionex- Director Technology BNFL Dr Rob Margetts Chair Legal and General plc Sir Paul Nurse President Rockefeller University Dr Raj Rajagopal CEO BOC Edwards Professor Michael Sterling Vice-Chancellor University of Birmingham Professor Kathy Sykes Bristol University Dr Mark Walport Director Wellcome Trust

5 How we operate Through networks - leaders from business, universities, regional organisations, Government Set up sub-groups and hold workshops and seminars to collect evidence and give direction Each project is sponsored by a Minister Three-person Secretariat

6 Science and Innovation Science, technology and Innovation Health and biotechnology Security Energy Productivity Trade Manufacturing Environment Pensions Services Foresight Education Horizon scanning G8 Climate change India Globalisation China EU Sustainable Development Framework Programme

7 Funding the Science Base Science Budget 1997 – 2014 (£m)

8

9 R&D:GDP Ratio (%) R&D to GDP ratio for the UK, of which 1.90% Science Base0.35% Other Government Depts R&D0.31% Private Sector1.24% France2.20% Germany2.51% USA2.67%

10

11 Our Innovation agenda Recognise the complex set of issues and interactions Ensure large Government investment in S&T, skills and education translate into innovation and wealth creation Need to encourage business to do more R&D

12 Our Innovation objectives Helping high-technology spin-outs and SMEs be more innovative and grow Connect services companies to the science base But recognise that wealth creation through innovation is not just about levels of R&D spend

13 Bridging the valley of death High tech SMEs large companies

14 Growing spin-outs and SMEs Increase their capacity to absorb R&D More focused use of public funding Better use of public procurement – contracts rather than grants Balancing risk, cost and longer-term benefits in R&D procurement policy

15 Bioscience SMEs NHS as a source of major competitive advantage to the UK UK pharmaceutical sector strong Biosciences as a growing source of high-tech start up and SMEs in the UK How to bring it all together?

16 Connecting Services companies to universities Services represent over 80% of the UK economy Poorly connected to the university base and Government But often high value-added businesses eg financial services and insurance

17 CST’s thinking Better strategic focus within Government for services sectors Common language and better metrics Architecture for knowledge transfer between services and universities Understand interactions between regulation, competition and innovation

18 Contact us Dr Peter Brooke Council for Science and Technology Bay Victoria St London Tel: